Cancer metabolism and autophagy is an emerging area generating a lot of attention. This is the area where Sprint Bioscience is developing drug candidates.
Want to meet with representatives from Sprint Bioscience to hear what we have in our pipeline and how we look upon the field?
Meet us at AACR in Washington April 6-10 or at BIO 2013 in Chicago April 21-25.
